financetom
Technology
financetom
/
Technology
/
Rpharmy CEO Laura Paxton Recognized in Becker’s Hospital Review’s ‘Patient Safety Experts to Know’ List
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rpharmy CEO Laura Paxton Recognized in Becker’s Hospital Review’s ‘Patient Safety Experts to Know’ List
Sep 17, 2025 11:25 AM

AUSTIN, Sept. 17, 2025 (GLOBE NEWSWIRE) -- On World Patient Safety Day, Rpharmy, a leading provider of medical formulary management and hazardous drug safety information software solutions, today announced that its founder and CEO, Laura Paxton, is one of the Becker’s Hospital Review 2025 “Patient Safety Experts to Know.” The complete list features individual profiles of the distinguished healthcare leaders.

“It’s an incredible honor to be recognized alongside more than 100 healthcare leaders who share my passion for patient safety, each bringing their unique perspective to this critical mission,” said Paxton. “We chose to announce this recognition on World Patient Safety Day to emphasize the importance of medication safety and patient safety. Our family experienced a devastating loss due to a preventable medication error which led to the founding of Rpharmy. Since then, we’ve dedicated our lives to ensuring other families never experience the heartbreak we felt. I know my mother-in-law would be proud of the work our entire team has accomplished in her memory, and I’m humbled that Becker’s Hospital Review has acknowledged our collective efforts to transform patient safety.”

Becker’s Hospital Review acknowledges that patients place tremendous trust in their healthcare providers, and annually takes time to honor patient safety experts who work tirelessly to protect patients from a wide scope of risks, from preventable errors to large-scale disasters. The individuals featured on this list are instrumental in reducing hospital-acquired infections, preventing adverse events and ensuring strict regulatory compliance. Becker’s Healthcare is proud to honor their achievements, recognizing the vital role they play in advancing patient safety and strengthening the quality of care within their organizations.

As CEO of Rpharmy, Paxton leads the company’s mission to enhance patient and healthcare worker safety through innovative, user-centered technology. What makes Laura Paxton stand out in healthcare IT isn’t just her technology; it’s her relentless focus on solving problems that others overlook. Paxton has pioneered tools that protect both patients and healthcare workers while building a culture of safety, equity, and practical innovation.

Under her direction, Rpharmy developed Formweb, a cloud-based formulary and safety platform that consolidates high-alert medications, REMS data, Black Box warnings, and facility-specific protocols into a single source of truth. More than just a formulary, it serves as a communication hub to improve patient safety across health systems.

Paxton also led the creation of Rhazdrugs, the first comprehensive software dedicated to hazardous drug handling safety and USP compliance. This solution was developed through constant engagement with nurses, pharmacists, and health system leaders who voiced concerns about the lack of clear, accessible safety guidance.

The Becker's Hospital Review editorial team accepted nominations for this list and chose the honorees to highlight the important work of patient safety experts across the U.S. To learn more about nominations, visit https://beckershealthcare.swoogo.com/list-nominations.

About Rpharmy

For more than 30 years, Rpharmy has been solving problems related to medication safety and patient care. We develop and provide technology focused on medical formulary, hazardous drug handling, and HFAP, NIOSH, and Joint Commission compliance. Our primary desire is to keep all patients and healthcare workers safe through easy access to critical medication safety information. For more information, visit https://www.rpharmy.com/

Media Contact:

Carrie Ward, PR for Rpharmy, 832-407-5347, [email protected]

Image: https://www.globenewswire.com/newsroom/ti?nf=OTUzMDE5OCM3MTQ5ODA1IzIzMDAyMTM=

Image: https://ml.globenewswire.com/media/NWZjZDVmMWUtZjFjYy00YjUwLWJmZTYtYTJmYWRhMTAwMzFmLTEzMTE3NjMtMjAyNS0wOS0xNy1lbg==/tiny/Rpharmy.png Image: Primary Logo

Source: Rpharmy

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Factbox-What are Biden's new tariffs on China goods?
Factbox-What are Biden's new tariffs on China goods?
May 14, 2024
WASHINGTON (Reuters) - President Joe Biden is hiking tariffs on $18 billion in Chinese goods including electric vehicles, batteries, semiconductors, steel, aluminum, critical minerals, solar cells, ship-to-shore cranes, and medical products, while retaining Trump-era tariffs on over $300 billion in goods. The United States Trade Representative's Office told Reuters it anticipates the effective date will be in approximately 90 days....
Biden sharply hikes US tariffs on billions in Chinese chips, cars
Biden sharply hikes US tariffs on billions in Chinese chips, cars
May 14, 2024
WASHINGTON, May 14 (Reuters) - U.S. President Joe Biden on Tuesday unveiled a bundle of steep tariff increases on an array of Chinese imports including electric vehicles, computer chips and medical products, risking an election-year standoff with Beijing in a bid to woo voters who give his economic policies low marks. Biden will keep tariffs put in place by his...
KKR to buy UK's geospatial software firm IQGeo
KKR to buy UK's geospatial software firm IQGeo
May 14, 2024
May 14 (Reuters) - KKR will buy UK's IQGeo Group in a deal valuing the geospatial software maker at 333 million pounds ($417.28 million), the companies said on Tuesday. ($1 = 0.7980 pounds) ...
Brent oil price forecast update 14-05-2024
Brent oil price forecast update 14-05-2024
May 14, 2024
Brent Oil Price Analysis Expected Scenario Brent oil price shows slight bearish bias now, affected by stochastic negativity. This reinforces the expectations of continuing the bearish trend in the upcoming sessions, waiting to test the 82.40$ level initially. Surpassing it will extend the bearish wave towards 80.08$. The bearish channel continues to organize the expected bearish wave, and it is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved